U.S., May 1 -- ClinicalTrials.gov registry received information related to the study (NCT07560059) titled 'Acute Metabolic Outcomes in Diabetic Patients Hospitalized for COVID-19 (DMD-COV)' on April 26.
Brief Summary: Diabetes is a major risk factor for severe COVID-19 and poor clinical outcomes during hospitalization. However, little is known about the medium- and long-term metabolic consequences of COVID-19 in people with diabetes after hospital discharge.
The DMD-COV study is a prospective, multicenter observational cohort conducted in Algeria. Its aim is to evaluate the cardio-metabolic outcomes of adult patients with diabetes who were hospitalized for confirmed COVID-19 and survived the acute phase of the infection.
Adult patients w...